ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,747Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 1278

$617K Total Retail Price of All Prescriptions

Rank: 68 out of 1278

756 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 756 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 756 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 9,269 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
METFORMIN HCL 515 367 1 4
LISINOPRIL 512 394 2 1
SIMVASTATIN 501 389 3 3
LEVOTHYROXINE SODIUM 500 380 4 2
OMEPRAZOLE 423 328 5 6
AMLODIPINE BESYLATE 301 266 6 5
HYDROCODONE-ACETAMINOPHEN 232 146 S3 7 7
MELOXICAM 222 147 8 57
FUROSEMIDE 202 163 9 10
GLIMEPIRIDE 182 156 10 61
WARFARIN SODIUM 181 145 11 17
HYDROCHLOROTHIAZIDE 180 154 12 8
METOPROLOL TARTRATE 176 147 13 9
LOVASTATIN 166 118 14 13
ZOLPIDEM TARTRATE 160 140 15 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 89 16 30
AMITRIPTYLINE HCL 144 110 R 17 55
LOSARTAN POTASSIUM 143 114 18 19
ATORVASTATIN CALCIUM 142 111 19 15
ATENOLOL 142 131 19 11
CITALOPRAM HBR 139 126 21 22
ALENDRONATE SODIUM 137 133 22 18
GABAPENTIN 136 88 23 12
GLIPIZIDE 128 124 24 35
DIOVAN 123 110 25 44
GLYBURIDE 113 96 R 26 40
TAMSULOSIN HCL 111 104 27 32
ALLOPURINOL 109 105 28 36
FLUOXETINE HCL 97 80 29 41
METOPROLOL SUCCINATE 96 73 30 23
POTASSIUM CHLORIDE 92 79 31 21
PANTOPRAZOLE SODIUM 89 85 32 34
TRAMADOL HCL 89 85 32 25
SPIRIVA 84 76 34 65
INSULIN SYRINGE 83 56 35 50
GEMFIBROZIL 81 42 36 54
NEXIUM 81 57 36 106
CRESTOR 79 71 38 31
LOSARTAN-HYDROCHLOROTHIAZIDE 79 78 38 75
LANTUS 78 49 40 33
PRAVASTATIN SODIUM 77 69 41 14
OXYCODONE HCL 72 22 S2 42 27
ADVAIR DISKUS 69 59 43 49
VYTORIN 66 66 44 85
DIGOXIN 59 59 45 79
NAMENDA 58 58 46 77
PREDNISONE 54 49 47 52
AZITHROMYCIN 54 43 47 37
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 34 47 90
LYRICA 54 39 47 104
CYMBALTA 53 51 51 67
RANITIDINE HCL 53 42 51 20
VENLAFAXINE HCL ER 51 43 53 121
PROAIR HFA 50 26 54 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.